Richard Ashworth

President and Chief Executive Officer at Amedisys Inc

Board

Since April 10, 2023

Age

50 years

Tenure

Joined as President and Chief Executive Officer on April 10, 2023, and has held significant leadership roles in the healthcare industry prior to joining, including positions at Tivity Health and Walgreen Co.

Also at Amedisys Inc

SGG

Scott G. Ginn

Chief Operating Officer

Denise Bohnert

Chief Compliance Officer

JGG

Jennifer Guckert Griffin

Chief Legal Officer

About

Richard Ashworth is a seasoned healthcare executive and pharmacist with over 30 years of industry experience, and he is 50 years old as of April 29, 2025.

He assumed the role of President and Chief Executive Officer at Amedisys on April 10, 2023, building on a career that includes leading positions such as CEO at Tivity Health and various executive roles at Walgreen Co..

His extensive background in operational management, strategic development, and transformational leadership—highlighted by his work with strategic partners like Alliance Boots—underscores his capability to drive growth and innovation within the healthcare sector.

$AMED Performance Under Richard Ashworth

Past Roles

Organization	Role	Date Range	Details
Tivity Health	President and CEO; Board Member	June 2020 - April 2023	Held concurrently as a Board Member
Walgreen Co.	President	February 2020 - June 2020	Responsible for developing strategies and plans for all Walgreens operations
Walgreen Co.	President of Operations	November 2017 - February 2020	N/A
Walgreen Co.	President of Pharmacy and Retail Operations	2014 - 2017	N/A
Walgreen Co.	Led Healthcare Strategy for Alliance Boots Partnership	2013	Developed and delivered the healthcare strategy leading to Walgreens' acquisition of Alliance Boots

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Annual Base Salary	$1,000,000	Annually	Fixed cash compensation
Annual Time-Based Stock Options	$1,250,000	Vestes one-third each year starting on February 20, 2024	33,711 options at an exercise price of $79.82 per share
Annual Time-Based RSUs	$1,250,000	Vestes one-third each year starting on February 20, 2024	15,661 RSUs
One-Time Time-Based RSUs	$2,500,000	100% vesting on April 12, 2024	31,321 RSUs
Special Equity Award (Time-Based RSUs)	$2,500,000	Vestes ratably over three years from June 26, 2023	27,410 RSUs
One-Time Cash Payment for Relocation and Expenses	$250,000	One-time payment	For relocation and expenses

Performance Compensation

Data from FY 2023

Annual Incentive (Cash Bonus) Plan

Metric	Details
Performance Measure	Adjusted EBITDA for 2023
Threshold	$216.2 million
Target	$240.2 million
Stretch/Maximum	$264.2 million
Payout Calculation	Dollar-for-dollar increments between threshold-target and target-stretch
TSR Modifier	75% (25th percentile and below), 100% (50th percentile), 125% (75th percentile and above)
Maximum Payout	200% of the target bonus
Vesting Schedule	Cliff vest at the end of the three-year performance period ending December 31, 2025
Grant Date	April 12, 2023
Target Bonus	$1,000,000 (100% of base salary)

Annual Performance-Based RSUs

Metric	Details
Performance Measure	Adjusted EBITDA for fiscal 2023
Threshold	75% of target performance at $216.2 million
Target	100% at $240.2 million
Stretch/Maximum	Up to 200% at $264.2 million
RSUs Granted (Target)	31,321 RSUs
RSUs Granted (Maximum)	62,642 RSUs
Actual Achievement	127.23% of target based on adjusted EBITDA of $247.0 million
Vesting Schedule	Cliff vest on February 20, 2026

One-Time Performance-Based RSUs

Metric	Details
Grant Date	April 12, 2023
Grant Date Fair Value	$5,000,000
RSUs Granted (Target)	62,641 RSUs
Payout Range	50% at threshold, 100% at target, up to 300% at maximum
Vesting Schedule	Cliff vest on April 12, 2028
Performance Condition	Based on the Company’s VWAP market cap as of April 12, 2026